AIM2 and renal carcinoma: To further validate our hypothesis that Ad‐CAIXpromotor‐AIM2 suppressed the growth of renal cancer cells by enhancing the inflammasome activation, 786‐O or OSRC‐2 was infected with Ad‐CAIXpromoter‐AIM2 or control Ads followed with or without the downstream inflammatory caspase inhibitor YVAD‐CMK.